2024 annual financial data
Monopar Therapeutics 2024 Net income growth
Direct answer
Net income growth was -85.5%.
Operating income was -16,161,721 USD and net income was -15,586,419 USD.
Operating cash flow was -6,404,139 USD.
Get free Monopar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -16,161,721 USD
- Net income
- -15,586,419 USD
- Operating cash flow
- -6,404,139 USD